Diabetes drug recalled over excess levels of cancer-causing agent

Marksans Pharma Limited, a pharmaceutical company in India, announced an expanded recalled of its Metformin hydrochloride extended-release tablets, a drug used to help those who suffer from type 2 diabetes to lower their blood glucose levels.

The recall, which was initially announced in June, was expanded on Monday to include an additional 76 unexpired lots of the medication.

“NDMA is a known environmental contaminant found in water and foods, including meats, dairy products and vegetables.

Marksans Pharma Limited has not received any reports of adverse events that have been related to this recall,” the FDA said.

It could be dangerous for patients with type 2 diabetes to stop taking their metformin without first talking to their health care professional,” the FDA warned.

The consumer “should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.”

Powered by Blogger.